Massachusetts-based biotech accelerator LabCentral signed an agreement with Hong Kong Science and Technology Parks Corporation in June to connect founders with the U.S. ecosystem—and fuel more innovation.
With China rising, Hong Kong builds bridge to biotech innovation
Annalee Armstrong